Age Group-specific Reference Intervals for the Elecsys Anti-Müllerian Hormone Assay in Healthy Korean Women: a Nationwide Population-based Study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Anti-Müllerian hormone (AMH) is one of the most reliable markers of ovarian reserve. Automated AMH assays are widely used in clinical laboratories, but reference intervals for the Elecsys AMH assay for Asian populations have not yet been determined. We aimed to determine reference intervals in healthy Korean women. Methods: The study included 1,450 women aged 19 to 54 years who participated in the Korea National Health and Nutrition Examination Survey between 2013 and 2016. The study participants were divided into seven 5-year age groups. AMH and progesterone concentrations were measured using Roche Elecsys assays, and bone morphogenetic protein-15 (BMP15) was genotyped for the detection of major variants. Age group-specific reference intervals for AMH were established as recommended by the CLSI EP28-A3c guidelines. Results: The mean age was 37.4 years. AMH concentrations decreased with increasing age, especially after 40 years, with the median AMH decreasing from 30.9 pmol/L in participants of 19–24 years to 0.071 pmol/L in participants of 50–54 years. The mid-95 percentile AMH reference intervals decreased from 7.93–81.21 pmol/L in participants of 19– 24 years to 0.07–3.86 pmol/L in participants of 50–54 years. Disease-associated BMP15 variants were not detected. Conclusions: We determined Elecsys AMH assay reference intervals in healthy Korean women. The results may provide basic information for the interpretation of AMH concentrations and assessment of ovarian reserve in Korean women.
Abstract
Background: Anti-Müllerian hormone (AMH) is one of the most reliable markers of ovarian reserve. Automated AMH assays are widely used in clinical laboratories, but reference intervals for the Elecsys AMH assay for Asian populations have not yet been determined. We aimed to determine reference intervals in healthy Korean women. Methods: The study included 1,450 women aged 19 to 54 years who participated in the Korea National Health and Nutrition Examination Survey between 2013 and 2016. The study participants were divided into seven 5-year age groups. AMH and progesterone concentrations were measured using Roche Elecsys assays, and bone morphogenetic protein-15 (BMP15) was genotyped for the detection of major variants. Age group-specific reference intervals for AMH were established as recommended by the CLSI EP28-A3c guidelines. Results: The mean age was 37.4 years. AMH concentrations decreased with increasing age, especially after 40 years, with the median AMH decreasing from 30.9 pmol/L in participants of 19–24 years to 0.071 pmol/L in participants of 50–54 years. The mid-95 percentile AMH reference intervals decreased from 7.93–81.21 pmol/L in participants of 19– 24 years to 0.07–3.86 pmol/L in participants of 50–54 years. Disease-associated BMP15 variants were not detected. Conclusions: We determined Elecsys AMH assay reference intervals in healthy Korean women. The results may provide basic information for the interpretation of AMH concentrations and assessment of ovarian reserve in Korean women.
참고문헌 (39)
- Dewailly D, "The physiology and clinical utility of anti-Mullerian hormone in women", Hum Reprod Update, 20, pp.370~385 (2014)
- Tal R, "Ovarian reserve testing : a user’s guide", Am J Obstet Gynecol, 217, pp.129~140 (2017)
- Podfigurna A, "Testing ovarian reserve in pre-menopausal women: why, whom and how?", Maturitas, 109, pp.112~117 (2018)
- Broer SL, "Anti-Müllerian hormone : ovarian reserve testing and its potential clinical implications", Hum Reprod Update, 20, pp.688~701 (2014)
- Ghazal Khaldoun, "Hormone Immunoassay Interference: A 2021 Update", Annals of Laboratory Medicine, 42(1), pp.3~23 (2022), 대한진단검사의학회[DOI]
- Gassner D, "First fully automated immunoassay for anti-Müllerian hormone", Clin Chem Lab Med, 52, pp.1143~1152 (2014)
- Demirdjian G, "Performance characteristics of the Access AMH assay for the quantitative determination of anti-Müllerian hormone(AMH)levels on the Access* family of automated immunoassay systems", Clin Biochem, 49, pp.1267~1273 (2016)
- van Helden J, "Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assay", Hum Reprod, 30, pp.1918~1926 (2015)
- Nelson SM, "Two new automated, compared with two enzyme-linked immunosorbent, antimüllerian hormone assays", Fertil Steril, 104, pp.1016~1021 (2015)
- Anckaert E, "Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination", Clin Biochem, 49, pp.260~267 (2016)
- Cheng X, "Establishing age-specific reference intervals for anti-Müllerian hormone in adult Chinese women based on a multicenter population", Clin Chim Acta, 474, pp.70~75 (2017)
- El-Attar EA, "Nomogram of age-specific anti-Müllerian hormone levels in healthy Egyptian females", PLoS One, 16, pp.e0254858~ (2021)
- Kim Sollip, "Schemes and Performance Evaluation Criteria of Korean Association of External Quality Assessment (KEQAS) for Improving Laboratory Testing", Annals of Laboratory Medicine, 41(2), pp.230~239 (2021), 대한진단검사의학회[DOI]
- "Measurands" (2022)[URL]
- Kotlyar AM, "Ethnicity", race and age-specific variations of serum AMH in women-A review, 2021, pp.11, 593216~
- Nelson SM, "Ethnic discordance in serum anti-Müllerian hormone in healthy women : a population study from China and Europe", Reprod Biomed Online, 40, pp.461~467 (2020)
- Bleil ME, "Race", ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race, Fertil Steril, pp.2014, 101[DOI]
- Ji Hee Yoo, "Age specific serum anti-Müllerian hormone levels in 1,298 Korean women with regular menstruation", Clinical and Experimental Reproductive Medicine, 38(2), pp.93~97 (2011), 대한생식의학회
- 이지은, "규칙적인 생리주기를 갖는 2,879명의 한국 여성에서의 나이에 따른 anti-Müllerian hormone 수치 분포에 관한 연구", Obstetrics & Gynecology Science, 55(12), pp.920~928 (2012), 대한산부인과학회[DOI]
- 이중엽, "Reference Values for the Revised Anti-Müllerian Hormone Generation II Assay: Infertile Population-based Study", Journal of Korean Medical Science, 32(5), pp.825~829 (2017), 대한의학회
- Zou Yutong, "Reference Intervals for Thyroid-Associated Hormones and the Prevalence of Thyroid Diseases in the Chinese Population", Annals of Laboratory Medicine, 41(1), pp.77~85 (2021), 대한진단검사의학회[DOI]
- Kim Y, "The Korea National Health and Nutrition Examination Survey(KNHANES) : current status and challenges", Epidemiol Health, 36, pp.e2014002~ (2014)
- Kweon S, "Data resource profile : the Korea National Health and Nutrition Examination Survey(KNHANES)", Int J Epidemiol, 43, pp.69~77 (2014)
- Rossetti R, "BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein", Hum Mutat, 30, pp.804~810 (2009)
- Pu D, "Gene variation and premature ovarian failure : a meta-analysis", Eur J Obstet Gynecol Reprod Biol, 182, pp.226~237 (2014)
- 남가은, "Obesity Fact Sheet in Korea, 2019: Prevalence of Obesity and Abdominal Obesity from 2009 to 2018 and Social Factors", Journal of Obesity & Metabolic Syndrome, 29(2), pp.124~132 (2020), 대한비만학회[DOI]
- Shin HY, "Recent trends in the prevalence of underweight, overweight, and obesity in Korean adults: the Korean National Health and Nutrition Examination Survey from 1998 to 2014", J Epidemiol, 27, pp.413~419 (2017)
- "Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity" (2011)[URL]
- Di Pasquale E, "Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15(BMP15)gene", Am J Hum Genet, 75, pp.106~111 (2004)
- Di Pasquale E, "Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure", J Clin Endocrinol Metab, 91, pp.1976~1979 (2006)
- Dixit H, "Missense mutations in the BMP15 gene are associated with ovarian failure", Hum Genet, 119, pp.408~415 (2006)
- Tukey JW, "Exploratory data analysis" (1977), Addison-Wesley Publishing Company
- CLSI, "Defining, establishing, and verifying reference intervals in the Clinical Laboratory; approved guideline" (2010), Clinical and Laboratory Standards Institute
- Han Aera, "Comparison of the Automated Fluorescent Immunoassay System With Roche Elecsys and Beckman Coulter Access 2 Assays for Anti-Müllerian Hormone Measurement", Annals of Laboratory Medicine, 42(1), pp.47~53 (2022), 대한진단검사의학회[DOI]
- Iliodromiti S, "Non-equivalence of anti-Müllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing", Hum Reprod, 32, pp.1710~1715 (2017)
- Shahrokhi SZ, "Anti-Mullerian hormone : genetic and environmental effects", Clin Chim Acta, 476, pp.123~129 (2018)
- Moslehi N, "Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis", Menopause, 25, pp.1046~1055 (2018)
- Rustamov O, "The measurement of anti-Müllerian hormone : a critical appraisal", J Clin Endocrinol Metab, 99, pp.723~732 (2014)
- Cho SY, "Opening of the national biobank of Korea as the infrastructure of future biomedical science in Korea", Osong Public Health Res Perspect, 3, pp.177~184 (2012)